CNR Institutional Research Information System

SCIANDRA, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.904
NA - Nord America 1.255
EU - Europa 1.147
SA - Sud America 398
AF - Africa 37
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.744
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.193
SG - Singapore 787
RU - Federazione Russa 656
CN - Cina 405
BR - Brasile 313
VN - Vietnam 231
HK - Hong Kong 204
IT - Italia 142
FR - Francia 137
KR - Corea 68
GB - Regno Unito 48
JP - Giappone 48
AR - Argentina 40
BD - Bangladesh 39
DE - Germania 38
NL - Olanda 34
CA - Canada 33
IN - India 32
FI - Finlandia 20
ID - Indonesia 17
EC - Ecuador 15
ZA - Sudafrica 15
IL - Israele 11
MX - Messico 11
TR - Turchia 11
CO - Colombia 8
IQ - Iraq 8
PL - Polonia 8
BE - Belgio 7
ES - Italia 7
LT - Lituania 7
PK - Pakistan 7
UA - Ucraina 7
AT - Austria 6
SA - Arabia Saudita 6
VE - Venezuela 6
AZ - Azerbaigian 5
CL - Cile 5
EG - Egitto 5
IE - Irlanda 4
OM - Oman 4
PA - Panama 4
PY - Paraguay 4
UY - Uruguay 4
BO - Bolivia 3
JM - Giamaica 3
JO - Giordania 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TN - Tunisia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BB - Barbados 2
CH - Svizzera 2
ET - Etiopia 2
HN - Honduras 2
HR - Croazia 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
MA - Marocco 2
MD - Moldavia 2
NI - Nicaragua 2
PH - Filippine 2
PT - Portogallo 2
SE - Svezia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AU - Australia 1
BS - Bahamas 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MK - Macedonia 1
MR - Mauritania 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 4.744
Salva come PNG Salva come JPEG
Città #
Santa Clara 503
Singapore 458
Hong Kong 202
Hefei 163
San Jose 140
Lauterbourg 94
Beijing 91
Ho Chi Minh City 79
Ashburn 73
Seoul 68
Los Angeles 57
Hanoi 53
Rome 48
Dallas 39
Milan 39
Tokyo 38
São Paulo 26
Frankfurt am Main 20
New York 19
Rio de Janeiro 15
Haiphong 14
Orem 14
London 12
Buffalo 11
Chennai 10
Lappeenranta 10
Da Nang 9
Helsinki 9
Johannesburg 9
Porto Alegre 9
Toronto 9
Belo Horizonte 8
Minamishinagawa 8
Brussels 7
Phoenix 7
Bengaluru 6
Brasília 6
Buenos Aires 6
Dhaka 6
Houston 6
Las Vegas 6
Montreal 6
Baghdad 5
Bexley 5
Bristol 5
Brooklyn 5
Campinas 5
Can Tho 5
Curitiba 5
Guayaquil 5
Hải Dương 5
Lahore 5
Manchester 5
Naples 5
Aracaju 4
Baku 4
Carapicuíba 4
Cleveland 4
Council Bluffs 4
Dublin 4
Düsseldorf 4
Lấp Vò 4
Ninh Bình 4
Nuremberg 4
Pittsburgh 4
Portsmouth 4
Roubaix 4
San Francisco 4
São José do Rio Preto 4
Treviso 4
Vienna 4
Warsaw 4
Acalanes Ridge 3
Amman 3
Anápolis 3
Bergamo 3
Blumenau 3
Boardman 3
Bogotá 3
Boston 3
Bình An 3
Bình Dương Province 3
Cairo 3
Cao Lanh 3
Chicago 3
Dakar 3
Didcot 3
Durban 3
Fortaleza 3
Genoa 3
Jakarta 3
Jeddah 3
Joinville 3
Kyiv 3
Marília 3
Montevideo 3
Mumbai 3
Ottawa 3
Panama City 3
Riyadh 3
Totale 2.629
Salva come PNG Salva come JPEG
Nome #
Analysis at the molecular level of the interaction between ±-dystroglycan and ²-dystroglycan and assessment of its implication for skeletal muscle physiopathology 722
Verbascoside Elicits Its Beneficial Effects by Enhancing Mitochondrial Spare Respiratory Capacity and the Nrf2/HO-1 Mediated Antioxidant System in a Murine Skeletal Muscle Cell Line 92
Molecular mechanisms underlying muscle wasting in huntington's disease 91
Analysis of the GFP-labelled β-dystroglycan interactome in HEK-293 transfected cells reveals novel intracellular networks 90
The missense mutation C667F in murine β-dystroglycan causes embryonic lethality, myopathy and blood-brain barrier destabilization 79
Activation of muscle-specific receptor tyrosine kinase and binding to dystroglycan are regulated by alternative mRNA splicing of agrin 75
A new monoclonal antibody DAG-6F4 against human alpha-dystroglycan reveals reduced core portein in some, but not all, dystroglycanopathy patients 68
Structural model of domain 1 of the alfa-dystroglycan glycosylating enzyme LARGE 68
3D Graphene Scaffolds for Skeletal Muscle Regeneration: Future Perspectives 64
Identification and Modeling of a GT-A Fold in the α-Dystroglycan Glycosylating Enzyme LARGE1 64
Multifunctional scaffolds for biomedical applications: Crafting versatile solutions with polycaprolactone enriched by graphene oxide 63
Discovery of 4-benzyloxy and 4-(2-phenylethoxy) chalcone fibrate hybrids as novel PPARα agonists with anti-hyperlipidemic and antioxidant activities: Design, synthesis and in vitro/in vivo biological evaluation 63
3D-printed graphene polylactic acid devices resistant to SARS-CoV-2: Sunlight-mediated sterilization of additive manufactured objects 62
Identification of the beta-dystroglycan binding epitope within the C-terminal region of alpha-dystroglycan. 57
Molecular and structural basis of dystroglycanopathies 57
A primary dystroglycanopathy causing muscle-eye-brain disease with multicystic leukodystrophy: from cellular and biochemical analysis to a mouse model 55
Structural flexibility of human ?lpha-dystroglycan 53
Identification and Modeling of a GT-A Fold in the ?-Dystroglycan Glycosylating Enzyme LARGE1 52
Synchrotron Radiation as a tool for the investigation of the structural basis of primary dystroglycanopathies. 51
A dystroglycan mutation (p.Cys667Phe) associated to muscle-eye-brain disease with multicystic leucodystrophy results in ER-retention of the mutant protein. 50
From adhesion complex to signaling hub: the dual role of dystroglycan 50
Advanced approaches in skin wound healing - a review on the multifunctional properties of MXenes in therapy and sensing 50
Alpha-dystroglycan is a potential target of matrix metalloproteinase MMP-2 49
Punicalagin Protects Human Retinal Pigment Epithelium Cells From Ultraviolet Radiation-Induced Oxidative Damage by Activating Nrf2/HO-1 Signaling Pathway and Reducing Apoptosis 49
The molecular basis of alpha-Dystroglycan hypoglycosylation: a crystallographic and SAXS study 49
The effect of the pathological V72I, D109N and T190M missense mutations on the molecular structure of ?-dystroglycan 47
Structural flexibility of human alpha-dystroglycan 47
The enzymatic processing of ?-dystroglycan by MMP-2 is controlled by two anchoring sites distinct from the active site 47
The enzymatic processing of ?-dystroglycan by MMP-2 is controller by two anchoring sites distinct from the active site 46
Perturbation of the alpha/beta-dystroglycan interaction: consequences for skeletal muscle stability 45
BPS2025 - Novel 3D-printed wound healing transwell system for reproducible analysis of skin dressing 45
Live optical super-resolution microcospy applied to the characterization of maturation, localization and trafficking of defective dystroglycan mutants 44
Concerted mutation of Phe residues belonging to the beta-dystroglycan ectodomain strongly inhibits the interaction with alpha-dystroglycan in vitro 43
Genetic Engineering of Dystroglycan in Animal Models of Muscular Dystrophy. 43
Modeling and molecular dynamics of alpha-dystroglycan's C-terminus reveals the presence of an Ig-like domain encompassing its beta-dystroglycan binding epitope 43
Novel thiazolidin-4-one benzenesulfonamide hybrids as PPARγ agonists: Design, synthesis and in vivo anti-diabetic evaluation 43
optical nanoscopy applied to the characterization of maturation and localization of defective dystroglycan mutants 43
Extracellular Vesicle Molecular Profiling for Diagnostic Purposes: An Application of Phage Display Technology 42
Structural model of domain 1 of the alfa-dystroglycan glycosylating enzyme LARGE 42
Analisi strutturale e funzionale dei domini del distroglicano: ruolo per la stabilità del muscolo e aspetti fisiopatologici 42
MicroRNA from human peripheral blood leukocytes and cardiovascular diseases 41
Insights from molecular dynamics simulations: Structural basis for the V567D mutation-induced instability of zebrafish alpha-dystroglycan and comparison with the murine model 40
?-Dystroglycan hypoglycosylation affects cell migration by influencing ?-dystroglycan membrane clustering and filopodia length: A musticale confocal microscopi analysis 39
A second Ig-like domain identified in dystroglycan by molecular modelling and dynamics 38
Design and synthesis of novel quinazolinone-based fibrates as PPARα agonists with antihyperlipidemic activity 38
Identification of the MMP-9 cleavage site on the recombinant b-dystroglycan ectodomain 38
Alpha-Dystroglycan is a potential target of matrix metalloproteinase MMP-2 37
A new monoclonal antibody DAG-6F4 against human alpha-dystroglycan reveals reduced core protein in some, but not all, dystroglycanopathy patients 37
Evaluating the role of the dystroglycan alpha/beta interface in human muscular dystrophies 36
Immunological dissection of the human dystroglycan complex 35
The Multiple Affinities of alpha-Dystroglycan 34
The structure of the T190M mutant of murine ?-dystroglycan at high resolution: insight into the molecular basis of a primary dystroglycanopathy 34
Evaluation of the effect of a floxed Neo cassette within the dystroglycan (Dag1) gene 34
Mutagenesis at the alpha-beta interface impairs the cleavage of the dystroglycan precursor 34
Evaluating the role of the dystroglycan alpha/beta interface in human muscular dystrophies 33
±- and ²-dystroglycan: evaluation of processing and targeting through multiple fluorescent tagging 33
Enzymatic processing by MMP-2 and MMP-9 of wild-type and mutated mouse ss-dystroglycan 33
First molecular characterization and immunolocalization of keratoepithelin in adult human skeletal muscle 33
The Structure of the T190M Mutant of Murine alpha-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy 32
Il Distroglicano, un recettore coinvolto nelle distrofie muscolari: dalla biochimica cellulare ad un modello murino. 32
Dystroglycan is associated to the disulfide isomerase ERp57 32
Mutagenesis of the ±- and ²- dystroglycan interface 32
Assessing the role of the ±/²-dystroglycan interface for the processing and maturation of the dystroglycan precursor 32
A synthetic peptide corresponding to the 550-585 region of alpha-dystroglycan binds beta-dystroglycan as revealed by NMR spectroscopy. 31
Analysis of dystroglycan in human patients affected by neuromuscular disorders.Analysis of dystroglycan in human patients affected by neuromuscular disorders 31
The molecular basis of alpha-dystroglycan hypoglycosylation: a crystallographic and SAXS study 31
The molecular basis of ?-dystroglycan hypoglycosylation: a crystallographic and SAXS study 31
Structural characterization by NMR of the natively unfolded extracellular domain of beta-dystroglycan: toward the identification of the binding epitope for alpha-dystroglycan. 30
Enzymatic Processing of beta-Dystroglycan Recombinant Ectodomain By MMP-9: Idendification of the Main Cleavage Site 30
An immunological analysis of dystroglycan subunits: lessons learned from a small cohort of non-congenital dystrophic patients. 30
Dystroglycan and muscular dystrophies related to the dystrophin-glycoprotein complex 29
Plasticity of secondary structure in the N-terminal region of beta-dystroglycan. 29
Quantification, 2DE analysis and identification of enriched glycosylated proteins from mouse muscles: Difficulties and alternatives 29
Dystroglycan: a possible mediator for reducing congenital muscular dystrophy? 29
Structural and functional analysis of the N-terminal extracellular region of beta-dystroglycan. 29
Structural characterization by NMR of the natively unfolded extracellular domain of beta-dystroglycan: toward the identification of the binding epitope for alpha-dystroglycan 28
Proteasome Activity Is Affected by Fluctuations in Insulin-Degrading Enzyme Distribution 28
The human keratoepithelin FAS1-4 domain as a model for the study of protein misfolding and amyloidogenesis: recombinant expression and preliminary characterisation 27
The Structure of the T190M Mutant of Murine alpha-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy 27
alpha-Dystroglycan does not play a major pathogenic role in autosomal recessive hereditary inclusion-body myopathy 27
Role of gelatinases in pathological and physiological processes involving the dystrophin-glycoprotein complex 27
Insights into the structure of the N-terminal region of alpha-dystroglycan: a concerted crystallographic and SAXS study 26
FRAP analysis of dystroglycan, a membrane receptor involved in congenital muscular dystrophies 26
Live cell optical super-resolution microscopy of dystroglycan mutants as a model for dystroglycanopathies in multiple cell lines 26
Biochemical and cellular analysis of the dystroglycan alpha/beta interface 26
Insertion of a myc-tag within alpha-dystroglycan domains improves its biochemical and microscopic detection 26
Analysis at the molecular level of the interaction between alfa-dystroglycan and beta-dystroglycan 26
Dystroglycan and muscular dystrophies related to the dystrophin-glycoprotein complex. 26
Immunodetection of partially glycosylated isoforms of alpha-dystroglycan by a new monoclonal antibody against its beta-dystroglycan-binding epitope 26
Biochemical analysis of dystroglycan mutants involved in muscular dystrophies 25
First genetic analysis of lattice corneal dystrophy type I in a family from Bulgaria 25
Identification of keratoepithelin in human skeletal muscle 25
Towards a reliable modeling approach for all dystroglycan domains 25
The structure of the N-terminal region of murine skeletal muscle alpha-dystroglycan discloses a modular architecture 25
Insertion of a myc-tag within ?-dystroglycan domains improves its biochemical and microscopic detection 24
Insights into the structure of the N-terminal region of ?-dystroglycan: a concerted crystallographic and SAXS study 23
Structural and functional aspects of dystroglycan: towards the elucidation of its pathophysiological role 22
Immunostaining of the sarcolemma with a new monoclonal antibody against alpha-dystroglycan core and its relevance to diagnosis 22
Alpha Dystroglycan monoclonal antibodies 22
MicroRNAs in human blood leukocytes and coronary angioplasy 21
Totale 4.682
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.087
article - articoli 8.555
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 115
Totale 22.757
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202418 0 0 0 0 0 0 0 0 6 6 4 2
2024/20251.706 1 6 115 48 393 217 16 117 51 66 390 286
2025/20263.017 114 232 283 375 374 125 318 116 805 106 113 56
2026/202789 89 0 0 0 0 0 0 0 0 0 0 0
Totale 4.830